The quarantine, sampling, testing, release of raw material, and/or the packaging materials prior to use were inadequate. The sampling, testing, and/or specifications for total microbial count were inadequate.
Inspection Record
PolyPeptide Laboratories Pvt Ltd — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.
The temperature and/or humidity control was inadequate. The premises were not constructed and/or maintained to allow cleaning and/or prevent the accumulation of foreign material. The premises and/or the manufacturing process were inadequate for minimizing contamination of the drugs and/or materials during fabrication and/or packaging.
The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions. The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-06-19. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
